70+ "Ioannis M.d" profiles | LinkedIn
Press Releases Archives - Page 2 of 4 - Averof II
70+ "Ioannis M.d" profiles | LinkedIn
CONGRESS GUIDE
Opsis Clinical | Medipass
SPEAKERS | Delphi Economic Forum
10+ "Ioannis" profiles | LinkedIn
Ioannis SANIDAS | Instructor | PhD | Harvard Medical School, MA | HMS | Department of Medicine
INNOMED-UP BLOG
Papalouka DIMITRA | MD | National and Kapodistrian University of Athens, Athens | uoa | Division of Surgery II
Use of interrupter technique in assessment of bronchial responsiveness in normal subjects | BMC Pulmonary Medicine | Full Text
PDF) Favourable effect of safinamide on mood over 2-year treatment of fluctuating Parkinson's disease patients
10+ "Ioannis" profiles | LinkedIn
PDF) Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: Results of a randomized, double-blind clinical study
ΜΑΝΩΛΗΣ ΚΟΤΤΑΚΗΣ – eretikos.gr
Percentage of all middle school and high school student who ever smoked... | Download Scientific Diagram
10+ "Ioannis" profiles | LinkedIn
Ioannis Kotsakiachidis - Business Developer & Marketeer - STIL B.V. | LinkedIn
ΜΑΝΩΛΗΣ ΚΟΤΤΑΚΗΣ – eretikos.gr
Effects of formoterol on exercise tolerance in severely disabled patients with COPD - Respiratory Medicine
Athens Churches & Cathedrals - Tripadvisor
Ιωάννης Παπαζήσης: «Έφτιαχναν ολόκληρες σελίδες μίσους στα social ή μου έστελναν είσαι σιχαμένος»
A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inhaler devices | npj Primary
Ioannis Kottakis MD,PhD,FCCP – Global Medical Head asthma – Novartis Pharma AG | LinkedIn
10+ "Ioannis" profiles | LinkedIn
Ioannis Kottakis MD,PhD,FCCP – Global Medical Head asthma – Novartis Pharma AG | LinkedIn
